Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Day one of HRS: Innovation and More
Wednesday, April 13, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

HRS Show Daily

Fitbit’s latest AFib algorithm receives FDA clearance, will be available ‘soon’

The new algorithm was designed to evaluate a user's heart rhythm while they are still or even sleeping. 

READ MORE >
Fitbit’s new algorithm for identifying signs of atrial fibrillation (AFib) has been cleared by the FDA. The photoplethysmography (PPG) algorithm was designed to passively evaluate a user’s heart rhythm while they are still or sleeping.
Share on Twitter Share on Facebook Share on Linkedin

Fitbit’s latest AFib algorithm receives FDA clearance, will be available ‘soon’

Share on Twitter Share on Facebook Share on Linkedin
Fitbit’s new algorithm for identifying signs of atrial fibrillation (AFib) has been cleared by the FDA. The photoplethysmography (PPG) algorithm was designed to passively evaluate a user’s heart rhythm while they are still or sleeping.
The new algorithm was designed to evaluate a user's heart rhythm while they are still or even sleeping. 
READ MORE >

Study links MRI findings with mental health disorders

Based on imaging, researchers suggested that gray matter volume could be a predictive marker of outcomes in mental health disorders, such as depression.

READ MORE >
Mental Health
Share on Twitter Share on Facebook Share on Linkedin

Study links MRI findings with mental health disorders

Share on Twitter Share on Facebook Share on Linkedin
Mental Health
Based on imaging, researchers suggested that gray matter volume could be a predictive marker of outcomes in mental health disorders, such as depression.
READ MORE >

Q&A U.S. and European Valvular Heart Disease Guidelines: Lessons from Across the Pond

Sponsored by Medtronic

“Good harmony” is the way John P. Erwin III, MD, describes the synergy of the 2021 ESC/EACTS Guidelines for the management of valvular heart disease (VHD) released in August along with the ACC/AHA guidelines that rolled in December 2020.

READ MORE >
erwin_stock.jpg
Share on Twitter Share on Facebook Share on Linkedin

Q&A U.S. and European Valvular Heart Disease Guidelines: Lessons from Across the Pond

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
erwin_stock.jpg
“Good harmony” is the way John P. Erwin III, MD, describes the synergy of the 2021 ESC/EACTS Guidelines for the management of valvular heart disease (VHD) released in August along with the ACC/AHA guidelines that rolled in December 2020.
READ MORE >

How the continued rise of TAVR has impacted SAVR outcomes

Did SAVR outcomes suffer due to the rapid rise of TAVR? A team of researchers aimed to find out with a brand new analysis. 

READ MORE >
surgery.jpg
Share on Twitter Share on Facebook Share on Linkedin

How the continued rise of TAVR has impacted SAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
surgery.jpg
Did SAVR outcomes suffer due to the rapid rise of TAVR? A team of researchers aimed to find out with a brand new analysis. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme